spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  nasal spray 

 HSMN NewsFeed - 16 Jul 2026
Lilly to Acquire AtaiBeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2026
Viatris Advances Innovative Portfolio with Approval of Effexor(R) in Japan for Adults with Generalized Anxiety Disorder (GAD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Aug 2024
FDA Approves First Nasal Spray for Treatment of Anaphylaxis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Dec 2022
Harm Reduction Therapeutics' New Drug Application for RiVive(TM) Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Oct 2022
Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Feb 2022
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
Devices Interventional Product Launch
 HSMN NewsFeed - 18 Oct 2021
Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 17 May 2021
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 8 Jun 2020
Neurelis Announces Rapid and Broad Payer Coverage of the Company's Flagship Product, VALTOCO(R) (Diazepam Nasal Spray)
Biopharmaceuticals Drug Delivery Reimbursement
 HSMN NewsFeed - 21 May 2020
Cipla Receives Final Approval for Generic Version of Migranal(R) (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 30 Apr 2020
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Oct 2019
Zyla Life Sciences Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch
 HSMN NewsFeed - 10 Sep 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 21 Aug 2019
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal(R) Nasal Spray
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jun 2019
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2019
UCB announces NAYZILAM(R) (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 May 2019
Glenmark Pharmaceuticals Announces Results from a Phase 3 Study of Ryaltris(TM), an Investigational Product for the Treatment of Seasonal Allergic Rhinitis, in Patients Aged 6 to Under 12 Years
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 5 Mar 2019
Perrigo Confirms Patent Challenge for Generic Version of Nascobal(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Feb 2019
Breckenridge Announces Final Approval of its ANDA for Exemestane Tablets (Aromasin(R))
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 3 Dec 2018
Neurelis Announces Acquisition Of Aegis Therapeutics, A Leading Drug Delivery Technology Company
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 31 Oct 2018
Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Narcan(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Sep 2018
Neurelis Files New Drug Application with the FDA for VALTOCO(TM) Nasal Spray, an Investigational Treatment for Pediatric, Adolescent and Adult Epilepsy Patients
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 9 Aug 2018
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Jun 2018
Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig(R) (zolmitriptan) Nasal Spray
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2018
ADAPT Pharma(R) Launches NARCANDirect.com
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 May 2018
Egalet Announces Large Regional Plan to Cover SPRIX(R) Nasal Spray
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 20 Apr 2018
UCB to Expand Epilepsy Portfolio With Strategic Acquisition of Midazolam Nasal Spray From Proximagen
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 27 Mar 2018
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude(R))
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Dec 2017
Robert Stewart to Join Amneal Pharmaceuticals as President
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2017
Egalet Receives FDA Tentative Approval for Expanded Label for ARYMO(R) ER (morphine sulfate) C-II, an Extended-Release Morphine Product Formulated with Abuse-Deterrent Properties for Treatment of Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Dec 2017
Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Oct 2017
Amneal And Impax To Combine
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 11 Jul 2017
The FDA has Accepted an Orphan Designation Request for use of Truveta Administered Intranasally Submitted by Axium Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Apr 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 11 Apr 2017
Amneal Introduces Its First Nasal Spray: Generic Nasonex(R)
Biopharmaceuticals Generics Drug Delivery Product Launch
 HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 7 Mar 2017
U.S. FDA Approves Serenity Pharmaceutical’s Noctiva(TM) (desmopressin acetate) – the First Drug Approved for the Treatment of Nocturia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2016
Egalet Appoints Patrick Shea as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2016
Egalet Settles Patent Litigations with Purdue Pharma
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Apr 2016
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 11 Apr 2016
Adapt Pharma Names Mike Kelly President of U.S. Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2016
Apotex Launches First Generic Version of Merck's Nasonex(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 29 Feb 2016
Egalet Announces FDA Acceptance of New Drug Application for ARYMO(TM) ER (Morphine Sulfate) Extended-Release Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Feb 2016
Lannett Receives FDA Approval For Sumatriptan Nasal Spray USP, 5mg And 20mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Feb 2016
Impax Receives Tentative FDA Approval for Generic Version of Vytorin(R) (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2015
Egalet Appoints Mark Strobeck, Ph.D. to Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Sep 2015
Depomed Files New Patent Infringement Lawsuit Against NUCYNTA(R) ER ANDA Filer
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Apr 2015
Depomed Announces Gralise(R) ANDA Litigation Settlement Confirming Exclusivity to 2024 and Dismissing Appeal
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Sep 2014
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2014
Retrophin Names Stephen Aselage President and Chief Operations Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Dec 2013
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Dec 2013
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 21 Nov 2013
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
Biopharmaceuticals Generics Dermatology Product Launch
 HSMN NewsFeed - 13 Nov 2013
Transcept Pharmaceuticals Announces Plans to Reduce Expenses Through a Reduction in Force and a Restructuring of its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2013
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2013
Acorda Therapeutics Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jun 2013
Dr. Larry Hsu, Impax Laboratories President and Chief Executive Officer, to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2013
Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Jan 2013
Acorda Therapeutics Announces Department of Defense Contract to Support Study of AC105 in Acute Spinal Cord Injury
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 21 Dec 2012
Acorda Therapeutics Announces Completion of Neuronex, Inc. Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2012
Sunovion Pharmaceuticals Inc. to Acquire Elevation Pharmaceuticals, Inc.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals
 HSMN NewsFeed - 29 Jul 2010
CMP Therapeutics Appoints Dr Neill Moray Mackenzie as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2010
Sepracor Inc. to Become Sunovion Pharmaceuticals Inc.
Biopharmaceuticals
 HSMN NewsFeed - 17 May 2010
ROXRO Announces FDA Approval of SPRIX(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 19 Apr 2010
Roxane Laboratories, Inc. Announces the Launch of Imipramine Pamoate Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 17 Dec 2009
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Sep 2009
Meda: FDA Approval of the First Once-Daily Nasal Antihistamine
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2009
DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2009
Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 May 2009
Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 1 Apr 2009
Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical
Biopharmaceuticals
 HSMN NewsFeed - 6 Feb 2009
ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 6 Jan 2009
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Nov 2008
Cancer Patients in Southern Florida Now Benefiting from RapidArc(TM) Radiotherapy Technology at Innovative Cancer Institute
Devices Oncology
 HSMN NewsFeed - 24 Oct 2008
European Medicines Agency (EMEA) Issues Positive Opinion For LUNIVIA(R) (Eszopiclone) Marketing Authorization Application (MAA) In Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Sep 2008
FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2008
DOR BioPharma Forms orBec(R) European Medical Advisory Board
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Meda Has Settled the U.S. Astelin Patent Litigation with Cobalt
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 Jul 2008
NASONEX(R) Now Approved in Japan for the Treatment of Allergic Rhinitis in Adult Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Jul 2008
Collegium Pharmaceutical Announces Completion of Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2008
Roxane Laboratories, Inc. Initiates a Nationwide Voluntary Recall of Two Manufacturing Lots of Sodium Polystyrene Sulfonate Suspension in the US and Puerto Rico
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 19 Jun 2008
Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Biopharmaceuticals
 HSMN NewsFeed - 12 May 2008
LUNESTA(R) Study of Patients with Insomnia and Co-Morbid Generalized Anxiety Disorder (GAD) Published in Archives of General Psychiatry
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R) Franchises
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor Announces Final Settlement of XOPENEX(R) Inhalation Solution Patent Infringement Litigation with Breath Limited
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor and Arrow Sign Global License and Development Agreement for XOPENEX(R)/Ipratropium Inhalation Solution Combination
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Apr 2008
Meda and Orexo in a Potential Billion SEK Deal
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 8 Apr 2008
Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents OMNARIS(TM) HFA Nasal Aerosol Large-Scale Phase II Study Data at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2008
Sepracor Presents Safety Data on OMNARIS(TM)AQ and OMNARIS(TM) HFA Nasal Sprays at American Academy of Allergy Asthma and Immunology (AAAAI)
Biopharmaceuticals
 HSMN NewsFeed - 28 Jan 2008
Sepracor Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 Jan 2008
Hi-Tech Pharmacal Receives Final Approval for Fluticasone Propionate Nasal Spray, 50mcg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Jan 2008
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2007
Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Dec 2007
Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2007
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Biopharmaceuticals
 HSMN NewsFeed - 19 Oct 2007
DOR BioPharma Receives Not Approvable Letter From FDA for orBec(R) for Treatment of Gastrointestinal Graft-versus-Host Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2007
Postoperative Pain is an Under Appreciated, Under Treated Problem in the United States
Pain Management Surgery
 HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2007
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
Biopharmaceuticals
 HSMN NewsFeed - 20 Jul 2007
Auriga Laboratories Appoints Lisa Tripodi as Vice President of Trade Relations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2007
Meda Enters the US Market Through the Strategic Acquisition of MedPointe Inc
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2007
Auriga Laboratories Appoints Rick Coulon Vice President of Consumer Brands
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jun 2007
King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jun 2007
Judgment Enters in Favor of Proveris Scientific Corporation in Patent Infringement Lawsuit against InnovaSystems, Inc.
Devices Drug Delivery Litigation
 HSMN NewsFeed - 16 May 2007
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Apr 2007
FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Apr 2007
FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Apr 2007
Intranasal Therapeutics, Inc. Appoints Pharmaceutical Industry Veteran, Peter F. Young, as President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Apr 2007
Adams Respiratory Therapeutics Highlights the Expansion and Diversification of its Product Portfolio
Biopharmaceuticals
 HSMN NewsFeed - 20 Mar 2007
DOR BioPharma Forms orBec(R) Medical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2007
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Feb 2007
Grifols Announces FDA Approval of Alphanate(R) to Treat von Willebrand Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Jan 2007
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2006
Nastech Pharmaceutical Company Inc. Provides Update on Parathyroid Hormone (PTH1-34) Nasal Spray for Treatment of Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Nov 2006
FDA Accepts DOR BioPharma's NDA Filing for orBec(R)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Nov 2006
Bentley Pharmaceuticals Expands Phase II Clinical Trials of Intranasal Insulin Spray to the U.S.
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 23 Oct 2006
ALTANA Pharma Receives Approval to Market Ciclesonide Nasal Spray in The U.S.
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Sep 2006
NovaDel Announces Positive Results from Pharmacokinetic Study of Improved Sumatriptan Oral Spray Formulation
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Sep 2006
Brian Tambi Resigns as Morton Grove Pharmaceuticals CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jun 2006
Nastech Pharmaceutical Company Inc. Enters into Development and License Agreement With Amylin Pharmaceuticals, Inc.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 May 2006
Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM)
Biopharmaceuticals
 HSMN NewsFeed - 10 May 2006
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
Biopharmaceuticals Drug Delivery Distribution
Return to NewsFeed  

 Additional items found! 75

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 75 additional stories matching:
nasal spray
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!